What do systematic reviews say?

PAE vs sham

• Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic… 2022 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 80 participants
  Very low

PAE vs TURP

It is very uncertain whether PAE changes major adverse events compared with TURP (very low certainty).

• Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic… 2022 · Cochrane Headline outcomes only
  RR 0.75 [0.19, 2.97]
  4 studies · 250 participants
  Very low

Transurethral microwave thermotherapy vs transurethral resection of the prostate

Transurethral microwave thermotherapy probably leads to lower major adverse events compared with transurethral resection of the prostate (moderate certainty).

• Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic… 2021 · Cochrane Headline outcomes only
  RR 0.2 [0.09, 0.43]
  6 studies · 525 participants
  Moderate

Transurethral microwave thermotherapy vs sham

• Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  8 studies · 924 participants
  Very low

Convective radiofrequency water vapour thermal therapy vs sham

It is very uncertain whether convective radiofrequency water vapour thermal therapy changes major adverse events compared with sham procedure (very low certainty).

• Convective radiofrequency water vapour thermal therapy for lower urinary tract symptoms in men with benign prostatic… 2020 · Cochrane Headline outcomes only
  RR 6.79 [0.39, 117]
  1 study · 197 participants
  Very low

PAE vs TURP

It is very uncertain whether PAE changes major adverse events compared with TURP (very low certainty).

• Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic… 2022 · Cochrane Headline outcomes only
  RR 0.91 [0.2, 4.05]
  2 studies · 206 participants
  Very low

PUL vs sham

It is very uncertain whether PUL changes major adverse events compared with sham (very low certainty).

• Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
  RR 3.3 [0.41, 26.28]
  1 study · 206 participants
  Very low

PUL vs TURP

It is very uncertain whether PUL changes major adverse events compared with TURP (very low certainty).

• Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
  RR 0.64 [0.18, 2.19]
  1 study · 79 participants
  Very low
• Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Aquablation vs transurethral resection of the prostate

It is very uncertain whether aquablation changes major adverse events compared with transurethral resection of the prostate (very low certainty).

• Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
  RR 0.84 [0.31, 2.26]
  1 study · 181 participants
  Very low

Higher polyunsaturated fatty acid (PUFA) vs lower PUFA

It is very uncertain whether higher polyunsaturated fatty acid (PUFA) changes major adverse cardiac and cerebrovascular events compared with lower PUFA (very low certainty).

• Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease 2018 · Cochrane Headline outcomes only
  RR 0.84 [0.59, 1.2]
  2 studies · 2879 participants
  Very low